GNH USA

Europe — EMA

Hexyon

Hexyon vaccine is a six‑component DTaP‑IPV‑Hib‑HepB injectable solution for pediatric immunization, protecting against diphtheria, tetanus, pertussis, polio, Hib and hepatitis B.

Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate), Diphtheria Toxoid, Teta

Request sourcing

1
Pack/s

What is Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate), Diphtheria Toxoid, Teta?

Hexyon is a combination vaccine that includes Haemophilus influenzae type b polysaccharide (PRP), diphtheria toxoid, tetanus toxoid, pertussis antigens, inactivated poliovirus types 1‑3, and hepatitis B surface antigen. It is supplied as an injectable solution for intramuscular use and is marketed in the European Union. Hexyon is indicated for infants and children following the recommended immunization schedule, protecting against six serious infectious diseases through a series of doses as part of routine care.

What is Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate), Diphtheria Toxoid, Teta used for?

Hexyon is used to actively immunize against multiple bacterial and viral pathogens in the pediatric population.

- Prevention of diphtheria, a serious bacterial infection that can cause throat and respiratory complications. - Prevention of tetanus, which can lead to muscle stiffness and spasms. - Prevention of pertussis (whooping cough), a contagious respiratory disease especially dangerous for infants. - Prevention of poliomyelitis caused by poliovirus types 1‑3, which can result in paralysis. - Prevention of Haemophilus influenzae type b disease, a leading cause of meningitis and pneumonia in young children. - Prevention of hepatitis B infection, a viral liver disease that can become chronic.

What are the side effects of Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate), Diphtheria Toxoid, Teta?

Local and systemic reactions may occur after intramuscular injection of Hexyon.

Common: - Pain, redness, or swelling at the injection site - Low‑grade fever - Irritability or fussiness in infants - Mild headache

Serious: - Severe allergic reaction (anaphylaxis) - High fever with seizures - Guillain‑Barré syndrome or other neurological symptoms

What precautions apply to Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate), Diphtheria Toxoid, Teta?

Healthcare providers should evaluate the patient’s health status before administering Hexyon and observe standard vaccination precautions.

- Do not vaccinate if there is a known severe allergy to any component of the vaccine. - Defer vaccination in the presence of moderate or severe acute illness. - Use caution in infants with a history of seizures. - Monitor the patient for at least 15 minutes after injection for immediate reactions. - Discuss expected local reactions and fever with caregivers. - Record the vaccine batch number and administration site for traceability. - Follow local guidelines for spacing from other live vaccines when required.

What does Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate), Diphtheria Toxoid, Teta interact with?

Hexyon may interact with other immunizations or immunomodulating agents; appropriate timing should be considered.

Avoid: - Simultaneous administration with live attenuated vaccines (e.g., measles‑mumps‑rubella) unless specifically recommended. - Co‑administration with blood products containing immunoglobulins that could neutralize vaccine antigens.

Use with caution: - Concurrent use of immunosuppressive therapy may reduce the antibody response. - Administration during acute febrile illness may increase reactogenicity. - Use in patients receiving other combination vaccines should follow recommended intervals. - Pregnant women should receive Hexyon only if the benefit outweighs potential risk.

Frequently asked questions

What diseases does Hexyon protect against?+
Hexyon provides immunization against diphtheria, tetanus, pertussis (whooping cough), poliomyelitis (polio types 1‑3), Haemophilus influenzae type b disease, and hepatitis B infection.
At what age is Hexyon typically started in the vaccination schedule?+
Hexyon is usually initiated in infancy, often beginning at 2 months of age, and is given as a series of doses according to national immunization programs.
Is Hexyon administered orally or by injection?+
Hexyon is administered as an intramuscular injection, typically into the thigh muscle of infants or the deltoid muscle of older children.
Can Hexyon be given together with other routine childhood vaccines?+
Hexyon can be co‑administered with many other non‑live vaccines, but live attenuated vaccines should be spaced according to local guidelines.
What are the most common side effects after receiving Hexyon?+
The most frequently reported reactions are mild pain, redness, or swelling at the injection site, low‑grade fever, irritability in infants, and mild headache.
What should be done if a severe allergic reaction occurs after Hexyon vaccination?+
If signs of anaphylaxis such as difficulty breathing, swelling of the face or throat, or rapid heartbeat appear, seek emergency medical care immediately and inform the healthcare provider.
Are there any contraindications for receiving Hexyon?+
Hexyon should not be given to individuals with a known severe allergy to any of its components or to those who have experienced a previous severe reaction to a DTaP‑IPV‑Hib‑HepB vaccine.
Does Hexyon provide lifelong immunity against hepatitis B?+
Hexyon induces protective antibodies against hepatitis B, but long‑term immunity may require booster doses according to national hepatitis B vaccination recommendations.
How does Hexyon differ from separate monovalent vaccines?+
Hexyon combines antigens for six diseases into a single injection, reducing the number of shots required and simplifying the immunization schedule compared with administering each vaccine separately.
Is Hexyon safe for use in children with weakened immune systems?+
Hexyon is generally safe, but children receiving immunosuppressive therapy may have a reduced antibody response; clinicians should assess the benefit‑risk balance in such cases.
What should parents monitor after their child receives Hexyon?+
Parents should watch for common reactions such as injection‑site soreness and mild fever, and seek medical attention if they notice signs of a serious reaction like persistent high fever, seizures, or allergic symptoms.
Can Hexyon be administered during pregnancy?+
Hexyon is not routinely recommended for pregnant women; it may be used only if the potential benefit to the mother outweighs any potential risk to the fetus.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Haemophilus Influenzae Type B Polysaccharide (Polyribosylribitol Phosphate), Diphtheria Toxoid, Teta
Route
Intramuscular Use
Manufacturer
Sanofi Winthrop Industrie
Origin
EU